Journal
NATURE MEDICINE
Volume 11, Issue 3, Pages 320-327Publisher
NATURE PORTFOLIO
DOI: 10.1038/nm1201
Keywords
-
Funding
- NIA NIH HHS [AG 21654, T32-AG023475] Funding Source: Medline
- NIDDK NIH HHS [DK 20541, DK 47208, DK52771, DK 48321, DK57671, DK 45024] Funding Source: Medline
Ask authors/readers for more resources
Increased glucose production is a hallmark of type 2 diabetes and alterations in lipid metabolism have a causative role in its pathophysiology. Here we postulate that physiological increments in plasma fatty acids can be sensed within the hypothalamus and that this sensing is required to balance their direct stimulatory action on hepatic gluconeogenesis. In the presence of physiologically-relevant increases in the levels of plasma fatty acids, negating their central action on hepatic glucose fluxes through (i) inhibition of the hypothalamic esterification of fatty acids, (ii) genetic deletion (Sur1-deficient mice) of hypothalamic K-ATP channels or pharmacological blockade (KATP blocker) of their activation by fatty acids, or (iii) surgical resection of the hepatic branch of the vagus nerve led to a marked increase in liver glucose production. These findings indicate that a physiological elevation in circulating lipids can be sensed within the hypothalamus and that a defect in hypothalamic lipid sensing disrupts glucose homeostasis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available